US pharmaceutical giant Pfizer will acquire Metsera, a maker of drugs for obesity and heart disease, for $4.9 billion, the companies said Monday.
This article was originally published on MedicalXpress.com
Pfizer to acquire obesity-drug maker Metsera for $4.9 bn
You may also be interested in:
The Latest
Setting Boundaries: Nurturing a Healthy Partnership
What Are Boundaries? As the word portrays, boundaries in a relationship help each person establish expectations with their partner. Boundaries can help you communicate what you are comfortable with and what you are willing to […]
The Latest
5 Popular Supplements in Canada for Optimal Health and Wellness
As a health and wellness enthusiast, I have always been interested in the role of supplements in promoting optimal health. In Canada, there are many supplements available on the market, each with different benefits and […]
The Latest
The Key to a Strong Relationship? Communication
Effective communication is the foundation of any strong, healthy relationship. This article will explore the key elements required to build better communication between partners. We’ll cover the importance of active listening, using empathy and understanding […]
Read More:
-
Results from a randomized clinical trial published in Pediatrics show that pediatricians who received targeted educational and clinical decision-support tools were significantly more likely to [...]
-
The U.S. Food and Drug Administration has approved Johnson & Johnson’s Tremfya (guselkumab) for the treatment of plaque psoriasis and active psoriatic arthritis in children [...]
-
Family affluence shields children from the risks of obesity and unhealthy eating habits, even when they’re surrounded by unhealthy food options, according to a study [...]
